Breaking News Instant updates and real-time market news.

MLNT

Melinta Therapeutics

$6.25

-0.2 (-3.10%)

05:26
05/24/18
05/24
05:26
05/24/18
05:26

Melinta Therapeutics 22M share Secondary priced at $5.00

The deal size was increased to $110M of common stock from $75M of common stock. JPMorgan and Jefferies acted as joint book running managers for the offering.

  • 24

    May

MLNT Melinta Therapeutics
$6.25

-0.2 (-3.10%)

11/30/17
GABE
11/30/17
UPGRADE
GABE
Hold
Melinta Therapeutics upgraded to Hold from Sell at Gabelli
11/30/17
11/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. The Medicines Co. (MDCO) upgraded to Outperform from Perform at Oppenheimer with analyst Jay Olson citing the company's "successful transformation" into a pure-play research and development biotech company focused entirely on inclisiran, an siRNA PCSK9 inhibitor. 2. Boston Scientific (BSX) upgraded to Buy from Neutral at BTIG with analyst Sean Lavin saying his prior Neutral rating was based on concerns that Lotus timelines were too aggressive and that the valve may never make it to the U.S. market. 3. Melinta Therapeutics (MLNT) upgraded to Hold from Sell at Gabelli. 4. Canadian National (CNI) upgraded to Buy on valuation at TD Securities with analyst Cherilyn Radbourne citing recent share price weakness. 5. HCA Healthcare (HCA) upgraded to Overweight from Neutral at JPMorgan with analyst Gary Taylor saying he is making a "relatively short-term call" that the currently proposed U.S. corporate tax reform would disproportionately benefit HCA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/09/18
BARD
05/09/18
UPGRADE
BARD
Outperform
Melinta Therapeutics upgraded to Outperform from Neutral at Baird
05/09/18
BARD
05/09/18
UPGRADE
Target $15
BARD
Outperform
Melinta Therapeutics upgraded to Outperform at Baird
As reported previously, Baird analyst Brian Skorney upgraded Melinta Therapeutics to Outperform from Neutral, citing valuation. He said sales of Baxdela and Vabomere could drive shares higher as the company already has four other commercial drugs already on the market. Skorney has a $15 price target on Melinta Therapeutics shares.

TODAY'S FREE FLY STORIES

ACBFF

Aurora Cannabis

$0.00

(0.00%)

, KO

Coca-Cola

$46.28

-0.04 (-0.09%)

10:16
09/18/18
09/18
10:16
09/18/18
10:16
Hot Stocks
Aurora Cannabis says no agreement for partnership with 'beverage company' »

Aurora Cannabis (ACBFF)…

ACBFF

Aurora Cannabis

$0.00

(0.00%)

KO

Coca-Cola

$46.28

-0.04 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/18/18
09/18
10:16
09/18/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
09/18/18
09/18
10:15
09/18/18
10:15
General news
U.S. NAHB housing market index was steady at 67 in September »

U.S. NAHB housing market…

10:15
09/18/18
09/18
10:15
09/18/18
10:15
General news
Treasury Action: yields remained elevated »

Treasury Action: yields…

ATHN

Athenahealth

$133.86

-9.395 (-6.56%)

10:13
09/18/18
09/18
10:13
09/18/18
10:13
Periodicals
Athenahealth extends bid date to accommodate new possible bidder, CNBC reports »

CNBC's David Faber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
09/18/18
09/18
10:10
09/18/18
10:10
General news
Housing Market Index data reported »

September Housing Market…

TLRY

Tilray

$135.75

15.55 (12.94%)

10:10
09/18/18
09/18
10:10
09/18/18
10:10
Options
Tilray options active with shares high as a kite »

Tilray options active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$96.09

0.09 (0.09%)

10:05
09/18/18
09/18
10:05
09/18/18
10:05
Hot Stocks
Medtronic announces FDA approval for revised TAVR labeling, begins study »

Medtronic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$132.62

12.42 (10.33%)

10:03
09/18/18
09/18
10:03
09/18/18
10:03
Periodicals
Citron Research calls Tilray news 'promotional and misleading' »

Citron Research just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBT

BB&T

$50.16

-0.08 (-0.16%)

10:01
09/18/18
09/18
10:01
09/18/18
10:01
Earnings
BB&T announces $5M investment in Enigma »

BB&T announced a $5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

GIS

General Mills

$44.99

-2.78 (-5.82%)

10:00
09/18/18
09/18
10:00
09/18/18
10:00
Technical Analysis
Technical Take: General Mills falls sharply after earnings »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 28

    Oct

BBY

Best Buy

$77.25

0.22 (0.29%)

10:00
09/18/18
09/18
10:00
09/18/18
10:00
Options
Notable short-term option spreads in Best Buy »

Notable short-term option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACBFF

Aurora Cannabis

$0.00

(0.00%)

09:58
09/18/18
09/18
09:58
09/18/18
09:58
Hot Stocks
Aurora Cannabis trading in Canada halted, pending news »

The Investment Industry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNP

Union Pacific

$164.22

7.49 (4.78%)

09:58
09/18/18
09/18
09:58
09/18/18
09:58
Conference/Events
Union Pacific to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 06

    Nov

UNP

Union Pacific

$164.03

7.3 (4.66%)

, FTI

TechnipFMC

$30.94

1.03 (3.44%)

09:55
09/18/18
09/18
09:55
09/18/18
09:55
Options
Early notable gainers among liquid option names on September 18th »

Notable gainers among…

UNP

Union Pacific

$164.03

7.3 (4.66%)

FTI

TechnipFMC

$30.94

1.03 (3.44%)

UHS

Universal Health

$131.36

5.33 (4.23%)

RIG

Transocean

$11.97

0.375 (3.23%)

HES

Hess Corp.

$68.20

1.41 (2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

09:55
09/18/18
09/18
09:55
09/18/18
09:55
General news
U.S. NAHB housing market index preview: »

U.S. NAHB housing market…

MBFI

MB Financial

$47.37

(0.00%)

, FITB

Fifth Third

$28.70

-0.01 (-0.03%)

09:50
09/18/18
09/18
09:50
09/18/18
09:50
Hot Stocks
MB Financial receives shareholder approval for merger with Fifth Third »

MB Financial (MBFI)…

MBFI

MB Financial

$47.37

(0.00%)

FITB

Fifth Third

$28.70

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 23

    Oct

UNP

Union Pacific

$163.89

7.16 (4.57%)

09:49
09/18/18
09/18
09:49
09/18/18
09:49
Technical Analysis
Technical Take: Union Pacific moves to new high, analyst action »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

FATE

Fate Therapeutics

$11.06

(0.00%)

09:49
09/18/18
09/18
09:49
09/18/18
09:49
Recommendations
Fate Therapeutics analyst commentary  »

Fate Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

AZO

AutoZone

$717.00

-30.53 (-4.08%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
AutoZone falls -4.2% »

AutoZone is down -4.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 29

    Oct

BRC

Brady

$43.45

-1.9 (-4.19%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
Brady falls -3.8% »

Brady is down -3.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WK

Workiva

$34.60

-3.2 (-8.47%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
Workiva falls -8.9% »

Workiva is down -8.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

SMG

Scotts Miracle-Gro

$79.42

0.45 (0.57%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Conference/Events
Scotts Miracle-Gro management to meet with SunTrust »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

UNP

Union Pacific

$164.33

7.6 (4.85%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
Union Pacific rises 4.8% »

Union Pacific is up 4.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CRC

California Resources

$38.68

1.91 (5.19%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
California Resources rises 5.5% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.